Bookmark and Share

Compound Summary for: CID 5328940

bosutinib

Also known as: SKI-606; 380843-75-4; SKI 606; SKI606; Bosutinib (USAN); UNII-5018V4AEZ0; CHEBI:39112; BOSULIF; AC1NS5P1
Molecular Formula: C26H29Cl2N5O3   Molecular Weight: 530.44616   InChIKey: UBPYILGKFZZVDX-UHFFFAOYSA-N
Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Compared to other tyrosine kinase inhibitors, it has a more favourable hematologic toxicity profile. FDA approved on September 4, 2012.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _